Ancestry‑gated Reproductive Enhancement

Commercial embryo‑selection tools that deliver useful predictive accuracy primarily for specific ancestral groups will produce a de facto two‑tier reproductive technology: high‑value enhancement for those whose genomes match training datasets and little or no benefit for others. That outcome will amplify socioeconomic and racial inequality, politicize reproductive services, and demand specific regulatory responses (disclosure, advertising limits, access mitigation). — If prediction accuracy remains ancestry‑dependent, private reproductive tech will create measurable demographic and equity consequences that require regulatory, clinical, and ethical policymaking now.